Protective effect on inhalated carbon monoxide for multiple organ dysfunction at cardiovascular surgery

吸入一氧化碳对心血管手术中多器官功能障碍的保护作用

基本信息

  • 批准号:
    15390413
  • 负责人:
  • 金额:
    $ 8.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Recently improvement of cardiovascular surgery, for instance, the method of cerebral perfusionCarbon monoxide (CO) can arrest cellular respiration, but paradoxically, it is synthesized endogenously by heme oxygenase type 1(Ho-1) in response to ischemic stress. Ho-1-deficient (Hmox1^<-/->) mice exhibited lethal ischemic lung injury, but were rescued from death by inhaled CO. CO drove ischemic protection by activating soluble guanylate cyclase and thereby suppressed hypoxic induction of the gene encoding plasminogen activator inhibitor-1(PAI-1) in mononuclear phagocytes, which reduced accrual of microvascular fibrin. CO-mediated ischemic protection observed in wild-type mice was lost in mice null for the gene encoding PAI-1 (Serpine1). These data establish a fundamental link between CO and prevention of ischemic injury based on the ability of CO to derepress the fibrinolytic axis. These data also point to a potential therapeutic use for inhaled CO.BACKGROUND : Myocardial ischemia-reperfu … More sion injury is a main cause of postoperative cardiac dysfunction, and a burst of proinflammatory cytokines, such as tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, and interleukin 8, plays a pivotal role. Recently, JTE-607 has been reported as a potent inhibitor of the multiple inflammatory cytokines in the endotoxin shock mouse model. In this study we proved the hypothesis that JTE-607 might attenuate myocardial ischemia-reperfusion injury in a rat model. METHODS : The isolated rat hearts in the JTE-607 preconditioning group (J group, n=8) or control group (C group, n=8) were subjected to warm ischemia (37 degrees C) for 30 minutes, followed by 60 minutes of reperfusion with the Langendorff perfusion system. RESULTS : Left ventricular developed pressure and maximum dp/dt after reperfusion were significantly improved in the J group than in the C group (P<.01). Creatine phosphokinase leakage is significantly lower in the J group (P<.05). Moreover, the tissue cytokine levels, such as tumor necrosis factor alpha, interleukin 6, and interleukin 8, in the myocardium were significantly lower in the J group than in the C group (P<.05). CONCLUSION : These results suggested that the pharmacologic preconditioning of JTE-607 inhibits a burst of endogenous cytokines in the myocardium, resulting in the improvement of cardiac function after ischemia-reperfusion injury. Thus JTE-607 might be a novel therapeutic strategy for the protection of postoperative cardiac dysfunction in cardiac surgery. Less
例如,最近改善心血管手术的方法,脑灌注碳一氧化碳(CO)的方法可以阻止细胞呼吸,但自相矛盾的是,它是由血红素氧酶1型(HO-1)响应缺血性压力而内源性的。 HO-1缺乏(HMOX1^<-/ - >)小鼠暴露了致命性缺血性肺损伤,但通过吸入CO驱动了缺血性保护酶,从而导致了缺血性保护酶,从而抑制了质体抑制剂抑制剂-1(PAI-1)在Modincielcience pai phag phag phag phag phag phag co co驱动了缺血性保护。纤维蛋白。在野生型小鼠中观察到的共同介导的缺血保护在无效的小鼠中丢失了编码PAI-1的基因(Serpine1)。这些数据基于CO消除纤溶轴的能力在CO与预防缺血性损伤之间建立了基本联系。这些数据还指出了遗传性二氧化碳的潜在疗法:心肌缺血 - reperfu…更多的sion损伤是表现后心脏功能障碍的主要原因,以及一系列促炎细胞因子,例如肿瘤坏死因子alpha,inthpha,interleukin beta 1 beta,interleukin beta,interleukin beta,interleukin beta,interleleukin 6&interleleal prowes prowes a prowes a prowes a prowes a prowes a prowes a prowes a prowes a prowes a in interlay a prowes a最近,据报道JTE-607是内毒素休克小鼠模型中多种炎症细胞因子的潜在抑制剂。在这项研究中,我们证明了JTE-607可以减弱大鼠模型中的心肌缺血 - 再灌注损伤的假设。方法:将JTE-607预处理组(J组,n = 8)或对照组(C组,n = 8)中的孤立大鼠心脏持续30分钟30分钟,然后与Langendorff灌注系统进行60分钟的再灌注。结果:与C组相比,J组的左心室发展压力和最大DP/DT显着改善(p <.01)。 J组的肌酸磷酸激酶泄漏显着降低(p <.05)。此外,在J组中,心肌中的组织细胞因子水平,例如肿瘤坏死因子α,白介素6和白介素8,高于C组(p <.05)。结论:这些结果表明,JTE-607的药理预处理抑制心肌中的内源性细胞因子爆发,导致缺血再灌注损伤后心脏功能改善。该JTE-607可能是一种在心脏手术中保护术后心脏功能障碍的新型治疗策略。较少的

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats.
Pharmacologicac preconditioning of JTE-607, a novel cytokine inhibitor, attenuates ischemia-reperfusion injury in the myocardium
JTE-607(一种新型细胞因子抑制剂)的药理预处理可减轻心肌缺血再灌注损伤
BH4 peptide derivative from Bcl-xl attenuates ischemia/reperfusion injury through anti-apoptotic mechanism in rat hearts.
Bcl-xl 的 BH4 肽衍生物通过抗凋亡机制减轻大鼠心脏的缺血/再灌注损伤。
150-kDa oxygen-regulated protein attenuates myocardial ischemia-reperfusion injury in rat heart
Pharmacologic preconditioning of JTE-607,1 novel cytokine inhibitor, attenuates ischemia-reperfusion injury in the myocardium.
JTE-607,1 新型细胞因子抑制剂的药理预处理可减轻心肌缺血再灌注损伤。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKANO Hiroshi其他文献

TAKANO Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKANO Hiroshi', 18)}}的其他基金

Induction of chromosome aberrations by Pulse Genome Editing system in mouse intestinal tumor
脉冲基因组编辑系统在小鼠肠道肿瘤中诱导染色体畸变
  • 批准号:
    19K07701
  • 财政年份:
    2019
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamics of nonlinear polymer systems
非线性聚合物系统动力学
  • 批准号:
    24540441
  • 财政年份:
    2012
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The elucidation of a mechanotransduction mechanism to the joint destruction in the temporomandibular joint synovial cell
颞下颌关节滑液细胞关节破坏的机械传导机制的阐明
  • 批准号:
    22592204
  • 财政年份:
    2010
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular biological analysis of bone metabolism by compressive mechanical stress in human synovial cells of the temporomandibular joint
人颞下颌关节滑膜细胞压缩机械应力对骨代谢的分子生物学分析
  • 批准号:
    18592196
  • 财政年份:
    2006
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Inducible Gene Targeting in Mice
小鼠诱导基因靶向的开发
  • 批准号:
    13680906
  • 财政年份:
    2001
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Simulational Analysis of Relaxation in Polymer Systems
聚合物体系松弛的模拟分析
  • 批准号:
    11640380
  • 财政年份:
    1999
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

ET-1激活II型肺泡上皮细胞STAT3通路抑制肺移植缺血再灌注损伤修复的机制研究
  • 批准号:
    82202412
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
ET-1激活II型肺泡上皮细胞STAT3通路抑制肺移植缺血再灌注损伤修复的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Maresin1抑制铁死亡减轻肺移植术后早期肺缺血再灌注损伤的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Maresin1抑制铁死亡减轻肺移植术后早期肺缺血再灌注损伤的作用及机制研究
  • 批准号:
    82100114
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
Irisin调节缺血再灌注损伤在自体肺移植中的作用及机制研究
  • 批准号:
    82070100
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Monocytic-MDSCs as resolution mediators of post-transplant lung ischemia-reperfusion injury
单核细胞-MDSC作为移植后肺缺血再灌注损伤的解决介质
  • 批准号:
    10677290
  • 财政年份:
    2023
  • 资助金额:
    $ 8.9万
  • 项目类别:
Evaluating the Clinical Relevance of Necroptosis in Ischemia Reperfusion Injury in Human Lung Transplants.
评估人肺移植缺血再灌注损伤中坏死性凋亡的临床相关性。
  • 批准号:
    485913
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
    Studentship Programs
Targeting Ischemia/Reperfusion Stress to Inhibit Cytomegalovirus Reactivation After Lung Transplant
针对肺移植后缺血/再灌注应激抑制巨细胞病毒再激活
  • 批准号:
    10453246
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
Aerosol Ventilation for Rapid Cooling of Transplant Donor Lungs
用于快速冷却移植供体肺的气雾通气
  • 批准号:
    10481907
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
Targeting the P Selectin Pathway to Improve ARDS Survival
靶向 P 选择通路以提高 ARDS 生存率
  • 批准号:
    10481283
  • 财政年份:
    2022
  • 资助金额:
    $ 8.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了